Chen Qinchang, Yu Jinjin, Huang Pingchuan, Huang Yulu, Chen Qingui, Zhang Zhiwei, Wang Shushui
Department of Pediatric Cardiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Structural Heart Disease, No. 106, Zhongshan 2nd Road, Guangzhou, China.
Department of Medical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Infect Dis Ther. 2022 Dec;11(6):2219-2232. doi: 10.1007/s40121-022-00702-z. Epub 2022 Oct 15.
Bloodstream infection (BSI) may occur after cardiac procedures, but this has rarely been investigated specifically in pediatric patients after percutaneous or surgical treatment for ventricular septal defect (VSD) or atrial septal defect (ASD) with recent data. The current study aimed to investigate the incidence, clinical features, and association with prognosis of BSI in this patient population.
Pediatric patients who received percutaneous or surgical procedure for VSD or ASD between 2010 and 2018 in a large children's hospital in China were retrospectively enrolled via the Pediatric Intensive Care database, but only those who had blood culture records within 24 h after the procedure and who had no prior positive blood culture records were included. BSI after the procedure was identified by reviewing blood culture records, and baseline characteristics associated with BSI were explored by univariable logistic regression. In-hospital mortality and length of hospitalization were studied as prognostic outcomes and compared between patients with and without BSI.
A total of 1340 pediatric patients were included. Among them, 46 (3.43%) patients had BSI within 24 h after the procedure, of which the majority (78.26%, 36/46) were caused by Gram-positive bacteria and 65.22% (30/46) had antibiotic-resistant organisms. Age [odds ratio (OR) 0.98 per 1-month increase, 95% confidence interval (CI) 0.97-1.00, P = 0.021] and antibiotic use within 72 h before the procedure (OR 1.81, 95% CI 1.00-3.26, P = 0.049) were statistically significantly associated with developing BSI. Compared with patients without BSI, there was no statistically significant difference in in-hospital mortality (0.00% versus 0.54%, P = 1.000), but patients with BSI had statistically significantly longer length of hospitalization (median 14.51 versus 12.94 days, P = 0.006), while the association was not statistically significant after adjustment for baseline characteristics by multivariable linear regression (β = 1.73, 95% CI -0.59 to 4.04, P = 0.144).
BSI is relatively uncommon in pediatric patients after procedures for VSD or ASD, but a younger age seems a risk factor. Developing BSI appears to be associated with increased length of hospitalization but not in-hospital mortality.
心脏手术后可能发生血流感染(BSI),但近期数据很少专门针对小儿室间隔缺损(VSD)或房间隔缺损(ASD)经皮或手术治疗后的患者进行研究。本研究旨在调查该患者群体中BSI的发生率、临床特征及其与预后的关系。
通过儿科重症监护数据库回顾性纳入2010年至2018年在中国一家大型儿童医院接受VSD或ASD经皮或手术治疗的儿科患者,但仅纳入术后24小时内有血培养记录且既往无血培养阳性记录的患者。通过查阅血培养记录确定术后BSI,并通过单因素逻辑回归探索与BSI相关的基线特征。将住院死亡率和住院时间作为预后指标进行研究,并比较有和没有BSI的患者。
共纳入1340例儿科患者。其中,46例(3.43%)患者在术后24小时内发生BSI,其中大多数(78.26%,36/46)由革兰氏阳性菌引起,65.22%(30/46)有耐药菌。年龄(每增加1个月比值比(OR)为0.98,95%置信区间(CI)为0.97-1.00,P = 0.021)和术前72小时内使用抗生素(OR 1.81,95%CI 1.00-3.26,P = 0.049)与发生BSI在统计学上显著相关。与没有BSI的患者相比,住院死亡率无统计学显著差异(0.00%对0.54%,P = 1.000),但有BSI的患者住院时间在统计学上显著更长(中位数14.51天对12.94天,P = 0.006),而多因素线性回归调整基线特征后该关联无统计学显著意义(β = 1.73,95%CI -0.59至4.04,P = 0.144)。
VSD或ASD手术后小儿患者中BSI相对少见,但年龄较小似乎是一个危险因素。发生BSI似乎与住院时间延长有关,但与住院死亡率无关。